REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 131 T, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Dr.Max 131 T, S.R.O. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Dr.Max 131 T, S.R.O. is a company in Slovakia, with a head office in Kosice. It operates in the Pharmacies and Drug Stores sector. The company was established on August 16, 2013. It currently has a total number of 5 - 9 (2025) employees. There was a net sales revenue increase of 33.57% reported in Dr.Max 131 T, S.R.O.’s latest financial highlights for 2025. Its’ total assets recorded a growth of 34.36%. The net profit margin of Dr.Max 131 T, S.R.O. increased by 0.39% in 2025.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 131 T, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 131 T, S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 131 T, S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 131 T, S.R.O. report to view the information.
Incorporation Date:
August 16, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 131 T, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
33.57%
Total Operating Revenue
33.47%
Operating Profit
93.17%
EBITDA
79.27%
Net Profit/Loss for the Period
67.02%
Total Assets
34.36%
Total Equity
28.21%
Operating Profit Margin
0.75%
Net Profit Margin
0.39%
Return on Equity (ROE)
5.11%
Debt / Equity
-0.28%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?